Page 21 - பயனுள்ள கற்பித்தல் ப்ர்யாக்டிஸஸ் நிச்சயமாக News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயனுள்ள கற்பித்தல் ப்ர்யாக்டிஸஸ் நிச்சயமாக. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயனுள்ள கற்பித்தல் ப்ர்யாக்டிஸஸ் நிச்சயமாக Today - Breaking & Trending Today

Welcome To IANS Live - TopStory - Govt employees to get full DA benefits from July

Photo Credit: IANS
IANSLive
New Delhi, March 9 (IANS) Central government employees and pensioners will get full benefits of dearness allowance starting July 1, with all the three pending installments being restored prospectively, Minister for State for Finance, Anurag Thakur said in Parliament on Tuesday
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 09-March-2021 ....

New Delhi , Anurag Thakur , Parliament On , News Service , India Private , All Rights , புதியது டெல்ஹி , அனுராக் தாகூர் , பாராளுமன்றம் ஆன் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application

(2)
SHELTON, CT / ACCESSWIRE / March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the Company ), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the strong effectiveness of its two COVID-19 clinical drug candidates in an animal model of coronavirus infection.
The Company is preparing a pre-IND application encompassing its two clinical drug candidates for the treatment of COVID-19 infected patients. Of these, NV-CoV-2 is the Company s broad-spectrum anti-coronavirus drug candidate based on its nanoviricides® platform that is expected to be capable of attacking most, if not all, SARS-CoV-2 variants and other coronaviruses. In addition, the Company is also developing NV-CoV-2-R that combines (1) the power of NV-CoV-2 to attack and potentially dismantle the virus particles outside cells, and (2) the power of remdesivir to block further production of virus particles inside cells. Blockin ....

United States , Dan Vergano , Anthony Fauci , Remdesivir Veklury , Exchange Commission , Committee For Medicinal Products Human , Nanoviricides Inc , Theracour Pharma Inc , European Medicines Agency , Drug Administration , Securities Exchange , Buzzfeed News , Better Surrogate Virus , Mol Med , Human Immunodeficiency Virus , Hepatitisb Virus , Hepatitisc Virus , Herpes Simplex Virus , Varicella Zoster Virus , Asian Bird Flu Virus , Japanese Encephalitis , West Nile Virus , Theracour Pharma , Securities Act , Securities Exchange Act , United States Securities ,

CDC Issues New Report on Face Mask Effectiveness

As more states drop COVID-19 restrictions, the CDC issued a report Friday saying coronavirus case counts went down when states mandated face masks and that coronavirus-related deaths went up in places when indoor dining resumed. ....

United States , West Virginia , Greg Abbott , Rochellep Walensky , National Restaurant Association , Mortality Weekly Report , Corona Virus , Covid 19 , Indoor Dining , ஒன்றுபட்டது மாநிலங்களில் , மேற்கு வர்ஜீனியா , கிரெக் அப்போட் , தேசிய உணவகம் சங்கம் , இறப்பு வாராந்திர அறிக்கை , கொரோனா வைரஸ் , சர்வதேச பரவல் , உட்புற சாப்பாட்டு ,

Corporate Office Properties Trust : COPT Elects Raymond L. Owens to Board of Trustees

Message :
Required fields
Corporate Office Properties Trust (“COPT” or the “Company”) (NYSE: OFC) announced that its Board of Trustees elected Raymond L. Owens to serve on the Company s Board, effective March 5, 2021.
“We are honored to welcome such a highly experienced, well-regarded real estate professional to COPT’s Board of Trustees,” stated Thomas F. Brady, Chairman of the Board. “In addition to having served as an executive at another public office REIT, Ray brings a wealth of capital markets and investment experience to our Board. We are excited to work with him and look forward to benefiting from the valuable perspectives he will bring,” he stated. ....

Ann Arbor , United States , Thomasf Brady , Raymondl Owens , Board Of Trustees , Corporate Office Properties Trust , Regional Office Properties , Piedmont Office Realty Trust , University Of Michigan , Master Of Business Administration In Marketing , Pm Realty Group , Company Board , Securities Exchange , Stephenm Ross School Of Business , Executive Vice President , Capital Markets , Chief Investment Officer , Managing Director , Wells Real Estate Funds , Senior Vice President , Business Administration , Real Estate , United States Government , Greater Washington , Regional Office , Securities Act ,

Italian lab develops monoclonal antibodies, one of the most effective Covid-19 treatments

06 Mar 2021 - 16:31
Chiara Albanese and Flavia Rotondi | Bloomberg
Tucked in the Tuscan hills around Siena in Italy, a research lab has come up with an antibody treatment for Covid-19 that its developers say will be 80 times more potent than the one given to former U.S. President Donald Trump in his most critical days in hospital last year.
The therapy is derived from the blood of people who’ve recovered from Covid, and relies on 453 different antibodies. It will also be administered as a single shot rather than a drawn-out infusion, which has been the norm for similar drugs. Clinical trials of about 3,000 doses produced so far started in Italy Thursday, and a roll out for general use could be approved as early as this summer. ....

Filippo Anelli , Donald Trump , Claudia Sala , Fabrizio Landi , Achille Sclavo , Giancarlo Giorgetti , Regeneron Pharmaceuticals Inc , Glaxosmithkline Plc , European Union , Astrazeneca Plc , Economic Development , Eli Lilly Co , Toscana Life Sciences Foundation , Italy Thursday , Monte Paschi , Siena Spa , Regeneron Pharmaceuticals , Zeneca Plc , Menarini Biotech , Development Minister Giancarlo Giorgetti , Covid 19 , பிலிப்போ னெல்லி , டொனால்ட் துருப்பு , கிளாடியா சலா , ஃபேப்ரிஜியோ லேண்டி , கிளாக்சோஸ்மித்க்லைன் ப்ல் ,